BIO

BIOtech Now’s Tracy Krughoff talks to Dr. David Agus of the University of Southern California’s Westside Prostate Cancer Center and the Center for Applied Molecular Medicine. His research focuses on the application of proteomics and genomics for the study of cancer and the development of new therapeutics for prostate cancer. Dr. Agus also is one of the judges for the Biotechnology Humanitarian Award, which will be given at the 2010 BIO International Convention.

Listen to the podcast:
http://www.bio.org/podcasts/agus.wma

Biosimilars, also known as follow-on biologics, may eventually expand access and provide patients a more affordable alternative to innovative, lifesaving medicines. However, there are a few important safeguards that must be put into place before these “similar but not the same” versions of biologics can be safely introduced to the public.  Join Dr.

Novozymes is an international corporation that is creating industrial biosolutions through over 700 products designed to improve industrial performance and safeguard the world's resources.  During a trip to their Franklinton, North Carolina-based facility, we learned about their work to create more efficient and environmentally friendly laundry detergents through the use of industrial enzymes.

Download to listen or view the podcast.

Yes, you heard it right. The FDA is contemplating the use of social media. One attendee,Porter Novelli's Peter Pitts, dubbed it,"Super Bowl of Part 15 Hearings.”

The hearing got,

"under way yesterday in a near-capacity federal conference hall.

This week, Farmer Gene blogs on biotechnology for sustainability, writing,

“On the Tomorrow’s Table blog, Kent J.

Washington, D.C. – October 7, 2009 – The Biotechnology Industry Organization (BIO) announced today that it is accepting nominations for the second annual Biotech Humanitarian Award. The Award will be given to an individual who, through their work in or support of biotechnology, has begun to harness its potential heal, fuel or feed the planet.

“Every day, biotech innovators work hard to unlock solutions to global issues,” said Jim Greenwood, president and CEO of BIO.

What is biotechnology?  Dr. David Targan, host of BioBytes, explains the basics of biotechnology and the many ways it affects our lives on a daily basis.

BIO President & CEO Jim Greenwood hosted a media briefing for reporters, editors and bloggers on February 26 to discuss President Obama’s address to Congress, the impact of the economy on the biotech industry, and BIO’s legislative priorities for 2009.